• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For August 15, 2022

    8/15/22 5:30:10 AM ET
    $ABOS
    $ADES
    $ALBO
    $AMPS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials
    Get the next $ABOS alert in real time by email

     

    Companies Reporting Before The Bell

    • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

    • GreenPower Motor Co (NASDAQ:GP) is estimated to report quarterly loss at $0.15 per share on revenue of $5.59 million.

    • Mondee Hldgs (NASDAQ:MOND) is likely to report quarterly loss at $0.04 per share on revenue of $38.94 million.

    • Reshape Lifesciences (NASDAQ:RSLS) is expected to report quarterly loss at $0.35 per share on revenue of $3.41 million.

    • Alaunos Therapeutics (NASDAQ:TCRT) is expected to report earnings for its second quarter.

    • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $0.19 per share on revenue of $5.25 million.

    • IM Cannabis (NASDAQ:IMCC) is estimated to report quarterly earnings at $0.01 per share on revenue of $20.60 million.

    • Wejo Gr (NASDAQ:WEJO) is expected to report earnings for its second quarter.

    • Impel Pharmaceuticals (NASDAQ:IMPL) is likely to report quarterly loss at $1.05 per share on revenue of $3.83 million.

    • TherapeuticsMD (NASDAQ:TXMD) is expected to report quarterly loss at $3.04 per share on revenue of $23.20 million.

    • SPDR Select Sector Fund - Consumer Discretionary (NYSE:XLY) is likely to report quarterly loss at $0.01 per share on revenue of $25.70 million.

    • SCYNEXIS (NASDAQ:SCYX) is expected to report earnings for its second quarter.

    • Medicenna Therapeutics (NASDAQ:MDNA) is likely to report earnings for its first quarter.

    • Roivant Sciences (NASDAQ:ROIV) is projected to report earnings for its first quarter.

    • Fathom Digital Mfg (NYSE:FATH) is expected to report quarterly loss at $0.01 per share on revenue of $43.46 million.

    • Gamida Cell (NASDAQ:GMDA) is likely to report earnings for its second quarter.

    • Viridian Therapeutics (NASDAQ:VRDN) is projected to report quarterly loss at $0.90 per share on revenue of $230 thousand.

    • Protalix BioTherapeutics (AMEX:PLX) is projected to report earnings for its second quarter.

    • ATAI Life Sciences (NASDAQ:ATAI) is expected to report earnings for its second quarter.

    • Stran & Co (NASDAQ:STRN) is projected to report earnings for its second quarter.

    • Li Auto (NASDAQ:LI) is projected to report quarterly loss at $0.06 per share on revenue of $1.12 billion.

    • Celsion (NASDAQ:CLSN) is estimated to report quarterly loss at $1.12 per share on revenue of $80 thousand.

    • CBAK Energy Tech (NASDAQ:CBAT) is estimated to report earnings for its second quarter.

    • Rockwell Medical (NASDAQ:RMTI) is projected to report earnings for its second quarter.

    • Stratus Properties (NASDAQ:STRS) is projected to report earnings for its second quarter.

    • Harbor Custom Dev (NASDAQ:HCDI) is expected to report quarterly earnings at $0.01 per share on revenue of $34.05 million.

    • Inuvo (AMEX:INUV) is projected to report quarterly loss at $0.01 per share on revenue of $20.05 million.

    • Stryve Foods (NASDAQ:SNAX) is expected to report quarterly loss at $0.33 per share on revenue of $13.45 million.

    • AEye (NASDAQ:LIDR) is likely to report quarterly loss at $0.15 per share on revenue of $830 thousand.

    • Sterling Bancorp (NASDAQ:SBT) is projected to report earnings for its second quarter.

    • Altus Power (NYSE:AMPS) is estimated to report earnings for its second quarter.

    • Weber (NYSE:WEBR) is estimated to report earnings for its third quarter.

    • WiSA Technologies (NASDAQ:WISA) is estimated to report earnings for its second quarter.

    • Gracell Biotechnologies (NASDAQ:GRCL) is estimated to report earnings for its second quarter.

    • Brainstorm Cell (NASDAQ:BCLI) is projected to report earnings for its second quarter.

    • Clear Secure (NYSE:YOU) is expected to report earnings for its second quarter.

    • Embecta (NASDAQ:EMBC) is expected to report quarterly earnings at $0.87 per share on revenue of $276.86 million.

    • Thoughtworks Holding (NASDAQ:TWKS) is likely to report quarterly earnings at $0.11 per share on revenue of $328.34 million.

    • Niu Technologies (NASDAQ:NIU) is projected to report earnings for its second quarter.

    • DouYu Intl Hldgs (NASDAQ:DOYU) is expected to report quarterly loss at $0.04 per share on revenue of $263.99 million.

    • UpHealth (NYSE:UPH) is projected to report quarterly loss at $0.08 per share on revenue of $45.00 million.

    • Gelesis Holdings (NYSE:GLS) is likely to report earnings for its second quarter.

    • Kalera (NASDAQ:KAL) is projected to report earnings for its second quarter.

    • Bitfarms (NASDAQ:BITF) is projected to report earnings for its second quarter.

    Companies Reporting After The Bell

    • Acumen Pharmaceuticals (NASDAQ:ABOS) is estimated to report earnings for its second quarter.

    • Vivos Therapeutics (NASDAQ:VVOS) is projected to report earnings for its second quarter.

    • GSE Systems (NASDAQ:GVP) is estimated to report earnings for its second quarter.

    • Navitas Semiconductor (NASDAQ:NVTS) is likely to report quarterly loss at $0.09 per share on revenue of $8.42 million.

    • Neptune Wellness Solns (NASDAQ:NEPT) is estimated to report quarterly loss at $2.45 per share on revenue of $18.00 million.

    • Tivic Health Systems (NASDAQ:TIVC) is projected to report earnings for its second quarter.

    • mCloud Technologies (NASDAQ:MCLD) is estimated to report earnings for its second quarter.

    • Biotricity (NASDAQ:BTCY) is estimated to report quarterly loss at $0.11 per share on revenue of $2.19 million.

    • Assure Hldgs (NASDAQ:IONM) is expected to report quarterly loss at $0.23 per share on revenue of $6.08 million.

    • Dolphin Entertainment (NASDAQ:DLPN) is projected to report quarterly earnings at $0.08 per share on revenue of $10.30 million.

    • iSun (NASDAQ:ISUN) is expected to report earnings for its second quarter.

    • Phoenix New Media (NYSE:FENG) is expected to report earnings for its second quarter.

    • Icecure Medical (NASDAQ:ICCM) is estimated to report earnings for its first quarter.

    • Stronghold Digital Mining (NASDAQ:SDIG) is projected to report earnings for its second quarter.

    • CVD Equipment (NASDAQ:CVV) is projected to report earnings for its second quarter.

    • Amtech Systems (NASDAQ:ASYS) is estimated to report quarterly loss at $0.28 per share on revenue of $14.72 million.

    • Quipt Home Medical (NASDAQ:QIPT) is expected to report earnings for its third quarter.

    • Blend Labs (NYSE:BLND) is projected to report quarterly loss at $0.19 per share on revenue of $58.32 million.

    • Verb Tech (NASDAQ:VERB) is likely to report quarterly loss at $0.06 per share on revenue of $2.93 million.

    • Midwest Holding (NASDAQ:MDWT) is projected to report quarterly loss at $0.21 per share on revenue of $10.40 million.

    • Greenidge Generation Hldg (NASDAQ:GREE) is expected to report quarterly loss at $0.12 per share on revenue of $46.10 million.

    • Enthusiast Gaming (NASDAQ:EGLX) is estimated to report quarterly loss at $0.09 per share on revenue of $50.26 million.

    • Kubient (NASDAQ:KBNT) is estimated to report quarterly loss at $0.22 per share on revenue of $1.20 million.

    • INVO Bioscience (NASDAQ:INVO) is likely to report quarterly loss at $0.24 per share on revenue of $330 thousand.

    • Biora Therapeutics (NASDAQ:BIOR) is estimated to report earnings for its second quarter.

    • Creative Realities (NASDAQ:CREX) is estimated to report earnings for its second quarter.

    • Arcimoto (NASDAQ:FUV) is estimated to report quarterly loss at $0.30 per share on revenue of $2.25 million.

    • F45 Training Holdings (NYSE:FXLV) is expected to report quarterly earnings at $0.14 per share on revenue of $50.17 million.

    • HyreCar (NASDAQ:HYRE) is expected to report quarterly loss at $0.25 per share on revenue of $10.46 million.

    • Blackboxstocks (NASDAQ:BLBX) is likely to report quarterly loss at $0.08 per share on revenue of $1.45 million.

    • Ginkgo Bioworks Holdings (NYSE:DNA) is likely to report quarterly loss at $0.04 per share on revenue of $77.63 million.

    • Ferroglobe (NASDAQ:GSM) is estimated to report quarterly earnings at $0.84 per share on revenue of $738.10 million.

    • SpringBig Holdings (NASDAQ:SBIG) is expected to report quarterly loss at $0.21 per share on revenue of $7.20 million.

    • Recruiter.Com Group (NASDAQ:RCRT) is likely to report quarterly loss at $0.25 per share on revenue of $7.20 million.

    • Sanara MedTech (NASDAQ:SMTI) is estimated to report earnings for its second quarter.

    • Sunlight Finl Hldgs (NYSE:SUNL) is expected to report quarterly earnings at $0.05 per share on revenue of $34.52 million.

    • Field Trip Health (NASDAQ:FTRP) is estimated to report quarterly loss at $0.16 per share on revenue of $1.79 million.

    • Fluence Energy (NASDAQ:FLNC) is likely to report quarterly loss at $0.34 per share on revenue of $227.93 million.

    • FiscalNote Holdings (NYSE:NOTE) is projected to report quarterly loss at $0.44 per share on revenue of $29.14 million.

    • Cemtrex (NASDAQ:CETX) is expected to report earnings for its third quarter.

    • Calithera Biosciences (NASDAQ:CALA) is expected to report earnings for its second quarter.

    • Immersion (NASDAQ:IMMR) is likely to report earnings for its second quarter.

    • American Res (NASDAQ:AREC) is estimated to report earnings for its second quarter.

    • Grupo Televisa (NYSE:TV) is projected to report quarterly loss at $0.03 per share on revenue of $68.84 million.

    • Charah Solns (NYSE:CHRA) is likely to report quarterly loss at $0.21 per share on revenue of $79.48 million.

    • TMC Metals (NASDAQ:TMC) is estimated to report earnings for its third quarter.

    • Nu Holdings (NYSE:NU) is expected to report earnings for its second quarter.

    • Advanced Emissions Solns (NASDAQ:ADES) is likely to report earnings for its second quarter.

    • Flexible Solutions Intl (AMEX:FSI) is estimated to report quarterly earnings at $0.07 per share on revenue of $9.55 million.

    • Fabrinet (NYSE:FN) is projected to report quarterly earnings at $1.54 per share on revenue of $581.50 million.

    • KULR Tech Gr (AMEX:KULR) is estimated to report quarterly loss at $0.03 per share on revenue of $880 thousand.

    • Gold Royalty (AMEX:GROY) is projected to report earnings for its third quarter.

    • AMMO (NASDAQ:POWW) is expected to report earnings for its first quarter.

    • Ideal Power (NASDAQ:IPWR) is estimated to report quarterly loss at $0.29 per share on revenue of $200 thousand.

    • Iridex (NASDAQ:IRIX) is projected to report quarterly loss at $0.15 per share on revenue of $13.92 million.

    • Duos Technologies Group (NASDAQ:DUOT) is projected to report quarterly loss at $0.26 per share on revenue of $2.70 million.

    • Nerdy (NYSE:NRDY) is likely to report earnings for its second quarter.

    • T2 Biosystems (NASDAQ:TTOO) is projected to report earnings for its second quarter.

    • GoHealth (NASDAQ:GOCO) is expected to report quarterly loss at $0.21 per share on revenue of $130.21 million.

    • Accelerate Diagnostics (NASDAQ:AXDX) is projected to report quarterly loss at $0.28 per share on revenue of $3.00 million.

    • CuriosityStream (NASDAQ:CURI) is expected to report quarterly loss at $0.28 per share on revenue of $20.99 million.

    • ThredUp (NASDAQ:TDUP) is projected to report earnings for its second quarter.

    • aTyr Pharma (NASDAQ:LIFE) is likely to report quarterly loss at $0.38 per share on revenue of $2.00 million.

    • Lucira Health (NASDAQ:LHDX) is likely to report quarterly loss at $0.34 per share on revenue of $30.05 million.

    • GreenBox POS (NASDAQ:GBOX) is likely to report quarterly loss at $0.20 per share on revenue of $5.66 million.

    • ENDRA Life Sciences (NASDAQ:NDRA) is likely to report earnings for its second quarter.

    • Peraso (NASDAQ:PRSO) is likely to report earnings for its second quarter.

    • Transphorm (NASDAQ:TGAN) is likely to report earnings for its first quarter.

    • Shoals Technologies Gr (NASDAQ:SHLS) is expected to report earnings for its second quarter.

    • Bird Glb (NYSE:BRDS) is estimated to report quarterly loss at $0.13 per share on revenue of $80.96 million.

    • Miromatrix Medical (NASDAQ:MIRO) is likely to report earnings for its second quarter.

    • Pioneer Power Solutions (NASDAQ:PPSI) is projected to report earnings for its second quarter.

    • WidePoint (AMEX:WYY) is expected to report earnings for its second quarter.

    • CYREN (NASDAQ:CYRN) is estimated to report earnings for its second quarter.

    • Remark Hldgs (NASDAQ:MARK) is projected to report earnings for its second quarter.

    • Quest Resource Holding (NASDAQ:QRHC) is projected to report earnings for its second quarter.

    • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its second quarter.

    • IZEA Worldwide (NASDAQ:IZEA) is estimated to report quarterly loss at $0.02 per share on revenue of $9.75 million.

    • Agora (NASDAQ:API) is estimated to report quarterly loss at $0.20 per share on revenue of $40.08 million.

    • Albireo Pharma (NASDAQ:ALBO) is estimated to report quarterly loss at $1.65 per share on revenue of $7.45 million.

    • CohBar (NASDAQ:CWBR) is likely to report earnings for its second quarter.

    • GAN (NASDAQ:GAN) is expected to report quarterly loss at $0.13 per share on revenue of $36.47 million.

    • Compass (NYSE:COMP) is expected to report quarterly loss at $0.14 per share on revenue of $2.12 billion.

    • Sema4 Holdings (NASDAQ:SMFR) is estimated to report earnings for its second quarter.

    • SomaLogic (NASDAQ:SLGC) is likely to report quarterly loss at $0.18 per share on revenue of $24.82 million.

    • Zenvia (NASDAQ:ZENV) is likely to report earnings for its second quarter.

    • IonQ (NYSE:IONQ) is likely to report quarterly loss at $0.10 per share on revenue of $2.39 million.

    • Urban-gro (NASDAQ:UGRO) is likely to report earnings for its second quarter.

    • SkyWater Technology (NASDAQ:SKYT) is estimated to report earnings for its second quarter.

    • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.07 per share on revenue of $1.23 billion.

    • ZipRecruiter (NYSE:ZIP) is projected to report quarterly earnings at $0.06 per share on revenue of $234.81 million.

    • Intercorp Financial Servs (NYSE:IFS) is likely to report quarterly earnings at $0.76 per share on revenue of $295.00 million.

    • Vicinity Motor (NASDAQ:VEV) is expected to report earnings for its second quarter.

    • Yunhong CTI (NASDAQ:CTIB) is likely to report earnings for its second quarter.

    • Burcon NutraScience (NASDAQ:BRCN) is likely to report earnings for its first quarter.

    • Panbela Therapeutics (NASDAQ:PBLA) is likely to report earnings for its second quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ABOS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABOS
    $ADES
    $ALBO
    $AMPS

    CompanyDatePrice TargetRatingAnalyst
    Clear Secure Inc.
    $YOU
    2/26/2026$45.00 → $55.00Outperform
    Telsey Advisory Group
    Shoals Technologies Group Inc.
    $SHLS
    2/25/2026$9.00Underperform → Neutral
    BNP Paribas Exane
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$33.00Buy
    Goldman
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$18.00Outperform
    Robert W. Baird
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$21.00Mkt Outperform
    Citizens
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$20.00Overweight
    Barclays
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$23.00Buy
    Deutsche Bank
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$13.00Overweight
    Analyst
    More analyst ratings

    $ABOS
    $ADES
    $ALBO
    $AMPS
    SEC Filings

    View All

    IonQ Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - IonQ, Inc. (0001824920) (Filer)

    2/27/26 5:23:08 PM ET
    $IONQ
    EDP Services
    Technology

    SEC Form 424B7 filed by IonQ Inc.

    424B7 - IonQ, Inc. (0001824920) (Filer)

    2/27/26 5:15:43 PM ET
    $IONQ
    EDP Services
    Technology

    SEC Form S-8 filed by Compass Inc.

    S-8 - Compass, Inc. (0001563190) (Filer)

    2/27/26 4:53:13 PM ET
    $COMP
    EDP Services
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Teuber William J Jr bought $115,155 worth of shares (3,000 units at $38.38), increasing direct ownership by 47% to 9,413 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    President and CEO Somo David M bought $250,000 worth of shares (90,909 units at $2.75), increasing direct ownership by 37% to 338,347 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    2/26/26 8:49:32 AM ET
    $IPWR
    Semiconductors
    Technology

    Chief Executive Officer O'Dowd William Iv bought $4,950 worth of shares (3,000 units at $1.65), increasing direct ownership by 0.68% to 440,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    2/24/26 7:08:09 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

    Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to regulatory approval as pivotal trials in treatment-resistant depression and anxiety advance through late-stage development[1]. The sector is shedding its countercultural reputation as biotech firms reposition serotonergic and psychedelic-derived therapies as mainstream pharmaceutical candidates[2]. Five companies are building the clinical programs to get there: Helus Pharma (NASDAQ:HELP), AtaiBeckley (NASDAQ:ATAI), Definium Therapeutics (NASDAQ:DFTX), GH Research (NASDAQ:GHRS), and LB Pharmaceuticals (NASDAQ:LBRX).

    2/27/26 11:44:00 AM ET
    $ATAI
    $DFTX
    $GHRS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products

    Ideal Power to Host Fourth Quarter and Full Year 2025 Results Conference Call on March 10, 2026 at 10:00 AM Eastern Time

    AUSTIN, Texas, Feb. 27, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will hold a conference call on Tuesday, March 10, 2026 at 10:00 AM Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2025. A press release detailing these results will be issued prior to the call.Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference call on March 1

    2/27/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Teuber William J Jr bought $115,155 worth of shares (3,000 units at $38.38), increasing direct ownership by 47% to 9,413 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    Executive Chair, IonQ Federal Cardillo Robert T. exercised 2,500 shares at a strike of $11.24, sold $203,685 worth of shares (5,165 units at $39.44) and covered exercise/tax liability with 3,071 shares, decreasing direct ownership by 5% to 109,220 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:05 PM ET
    $IONQ
    EDP Services
    Technology

    Director Wiener Adam sold $1,525,280 worth of shares (33,000 units at $46.22), decreasing direct ownership by 20% to 132,634 units (SEC Form 4)

    4 - Clear Secure, Inc. (0001856314) (Issuer)

    2/27/26 7:47:03 PM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Clear Secure with a new price target

    Telsey Advisory Group reiterated coverage of Clear Secure with a rating of Outperform and set a new price target of $55.00 from $45.00 previously

    2/26/26 6:51:04 AM ET
    $YOU
    Computer Software: Prepackaged Software
    Technology

    Shoals Technologies upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded Shoals Technologies from Underperform to Neutral and set a new price target of $9.00

    2/25/26 7:38:45 AM ET
    $SHLS
    Semiconductors
    Technology

    Goldman initiated coverage on Ethos Technologies with a new price target

    Goldman initiated coverage of Ethos Technologies with a rating of Buy and set a new price target of $33.00

    2/23/26 8:37:19 AM ET
    $LIFE
    Specialty Insurers
    Finance

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Financials

    Live finance-specific insights

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Ideal Power to Host Fourth Quarter and Full Year 2025 Results Conference Call on March 10, 2026 at 10:00 AM Eastern Time

    AUSTIN, Texas, Feb. 27, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will hold a conference call on Tuesday, March 10, 2026 at 10:00 AM Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2025. A press release detailing these results will be issued prior to the call.Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference call on March 1

    2/27/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    Li Auto Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    BEIJING, China, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 before the U.S. market opens on Thursday, March 12, 2026. The Company's management will hold an earnings conference call on Thursday, March 12, 2026, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will

    2/27/26 4:00:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Leadership Updates

    Live Leadership Updates

    View All

    Duos Technologies Group, Inc. Signs ~$200M LOI and Appoints Doug Recker as CEO

    3-Year NVIDIA GPU hosting LOI delivers $40M+ annual EBITDA 10MW site secured to accelerate expansion of distributed AI infrastructure in 2026  JACKSONVILLE, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT) has signed a non-binding letter of intent ("LOI") with Hydra Host to deploy a high-density NVIDIA GPU cluster for a leading global technology customer. The project supports an underlying GPU-as-a-Service ("GPUaas") partnership that is expected to generate approximately $176 million in revenue over a 36-month term. The deployment is modeled to support gross margins more than 80% and projected annual EBITDA exceeding $40 million

    2/27/26 8:30:00 AM ET
    $DUOT
    Computer Software: Prepackaged Software
    Technology

    AtaiBeckley Appoints Michael Faerm as Chief Financial Officer

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc (NASDAQ:ATAI) ("AtaiBeckley" or the "Company"), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced the appointment of Michael Faerm as Chief Financial Officer, effective March 9, 2026. Mr. Faerm is a seasoned financial executive with more than 25 years of experience across life sciences companies, equity research, and investment banking. As Chief Financial Officer at AtaiBeckley, he will lead the Company's financial strategy, capital markets activities, and overall financial operations. Anne Johnson, who ha

    2/19/26 7:00:00 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target, REalloys to Appoint Bob Foresman to its Board of Directors

    Following the Addition of General Jack Keane, REalloys Further Strengthens Board with Addition of Former Vice Chairman of UBS Investment Bank  Blackboxstocks/REalloys Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close the merger DALLAS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has entered into a designate director agreement with Bob Foresman. Mr. Foresman will formally join the REalloys Board of Directors upon the closing of the merger between Blackboxstocks and REalloys. Blackboxstocks' regist

    2/18/26 8:00:00 AM ET
    $BLBX
    EDP Services
    Technology

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ABOS
    $ADES
    $ALBO
    $AMPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care